Functional analysis of the NUP98-CCDC28A fusion protein

Haematologica

Volumn 97, Issue 3, 2012, Pages 379-387

  Petit, Arnaud ^a,i   Ragu, Christine ^a,j   Soler, Gwendoline ^a,b   Ottolenghi, Chris ^a,b   Schluth, Caroline ^a   Radford Weiss, Isabelle ^c   Schneider Maunoury, Sylvie ^d   Callebaut, Isabelle ^e   Dastugue, Nicole ^f   Drabkin, Harry A ^g   Bernard, Olivier A ^a,h   Romana, Serge ^a,c   Penard Lacronique, Virginie ^a,h  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d CNRS and Université Pierre et Marie Curie   (France)

^e UNIVERSITÉ PIERRE ET MARIE CURIE   (France)

^f CHU PURPAN   (France)

^g MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^h UNIVERSITÉ PARIS SACLAY   (France)

ⁱ ARMAND TROUSSEAU HOSPITAL   (France)

^j MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

more..

Author keywords

Mouse model; NUP98 fusions; T ALL

Indexed keywords

HYBRID PROTEIN; NUP98 COILED COIL DOMAIN CONTAINING PROTEIN 28A; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CCDC28A GENE; CELL EXPANSION; CELL PROLIFERATION; CONTROLLED STUDY; GENE TRANSLOCATION; GRANULOCYTE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; MACROPHAGE; NONHUMAN; NUCLEOTIDE SEQUENCE; NUP98 GENE; ONCOGENE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SEQUENCE ALIGNMENT;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CELL NUCLEUS; CELL PROLIFERATION; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 6; GENE EXPRESSION; GRANULOCYTE-MACROPHAGE PROGENITOR CELLS; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOPHENOTYPING; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; MYELOPROLIFERATIVE DISORDERS; NEOPLASM PROTEINS; NUCLEAR PORE COMPLEX PROTEINS; ONCOGENE PROTEINS, FUSION; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROTEIN ISOFORMS; PROTEIN TRANSPORT; PROTEINS; SEQUENCE ALIGNMENT; TRANSLOCATION, GENETIC;

EID: 84857712578     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2011.047969     Document Type: Article

References (35)

1. Jeganathan KB, Baker DJ, van Deursen JM. Securin associates with APCCdh1 in prometaphase but its destruction is delayed by Rae1 and Nup98 until the meta-phase/anaphase transition. Cell Cycle. 2006;5(4):366-70.
2. Kalverda B, Pickersgill H, Shloma VV, Fornerod M. Nucleoporins directly stimulate expression of developmental and cell-cycle genes inside the nucleoplasm. Cell. 2010; 140(3):360-71.
3. Wu X, Kasper LH, Mantcheva RT, Mantchev GT, Springett MJ, van Deursen JM. Disruption of the FG nucleoporin NUP98 causes selective changes in nuclear pore complex stoichiometry and function. Proc Natl Acad Sci USA. 2001;98 (6):3191-6.
4. Romana SP, Radford-Weiss I, Ben Abdelali R, Schluth C, Petit A, Dastugue N, et al. NUP98 rearrangements in hematopoietic malignancies: a study of the Groupe Francophone de Cytogenetique Hematologique. Leukemia. 2006;20(4):696-706.
5. Kasper LH, Brindle PK, Schnabel CA, Pritchard CE, Cleary ML, van Deursen JM. CREB binding protein interacts with nucleoporin-specific FG repeats that activate transcription and mediate NUP98-HOXA9 oncogenicity. Mol Cell Biol. 1999;19(1): 764-76.
6. Dorsam ST, Takeda A, Camarata T, Moore MA, Viale A, Yaseen NR. The transcriptome of the leukemogenic homeoprotein HOXA9 in human hematopoietic cells. Blood. 2004;103(5):1676-84.
7. Ghannam G, Takeda A, Camarata T, Moore MA, Viale A, Yaseen NR. The oncogene Nup98-HOXA9 induces gene transcription in myeloid cells. J Biol Chem. 2004;279 (2):866-75.
8. Petit A, Ragu C, Della-Valle V, Mozzi conacci MJ, Lafage-Pochitaloff M, Soler G, et al. NUP98-HMGB3: a novel oncogenic fusion. Leukemia. 2010;24(3): 654-8.
9. Kaltenbach S, Soler G, Barin C, Gervais C, Bernard OA, Penard-Lacronique V, Romana SP. NUP98-MLL fusion in human acute myeloblastic leukemia. Blood. 2010;116 (13):2332-5.
10. Panagopoulos I, Kerndrup G, Carlsen N, Strombeck B, Isaksson M, Johansson B. Fusion of NUP98 and the SET binding protein1 (SETBP1) gene in a paediatric acute T cell lymphoblastic leukaemia with t(11;18)(p15;q12). Br J Haematol. 2007;136 (2):294-6.
11. van Zutven LJ, Onen E, Velthuizen SC, van Drunen E, von Bergh AR, van den Heuvel-Eibrink MM. Identification of NUP98 abnormalities in acute leukemia: JARID1A (12p13) as a new partner gene. Genes Chromosomes Cancer. 2006;45(5):437-46.
12. Reader JC, Meekins JS, Gojo I, Ning Y. A novel NUP98-PHF23 fusion resulting from a cryptic translocation t(11;17)(p15;p13) in acute myeloid leukemia. Leukemia. 2007; 21(4):842-4.
13. Rayasam GV, Wendling O, Angrand PO, Mark M, Niederreither K, Song L. NSD1 is essential for early post-implantation development and has a catalytically active SET domain. Embo J. 2003;22(12):3153-63.
14. Sutherland HG, Newton K, Brownstein DG, Holmes MC, Kress C, Semple CA, Bickmore WA. Disruption of Ledgf/Psip1 results in perinatal mortality and homeotic skeletal transformations. Mol Cell Biol. 2006;26(19):7201-10.
15. Christensen J, Agger K, Cloos PA, Pasini D, Rose S, Sennels L, et al. RBP2 belongs to a family of demethylases, specific for tri-and dimethylated lysine 4 on histone 3. Cell. 2007;128(6):1063-76.
16. Yokoyama A, Cleary ML. Menin critically links MLL proteins with LEDGF on cancerassociated target genes. Cancer Cell. 2008;14(1):36-46.
17. Wang GG, Cai L, Pasillas MP, Kamps MP. NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis. Nat Cell Biol. 2007;9(7):804-12.
18. Palmqvist L, Pineault N, Wasslavik C, Humphries RK. Candidate genes for expansion and transformation of hematopoietic stem cells by NUP98-HOX fusion genes. PLoS ONE. 2007;2(1):e768.
19. Jankovic D, Gorello P, Liu T, Ehret S, La Starza R, Desjobert C, et al. Leukemogenic mechanisms and targets of a NUP98/HHEX fusion in acute myeloid leukemia. Blood. 2008;111(12):5672-82.
20. Wang GG, Song J, Wang Z, Dormann HL, Casadio F, Li H, et al. Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger. Nature. 2009;459(7248):847-51.
21. Yassin ER, Abdul-Nabi AM, Takeda A, Yaseen NR. Effects of the NUP98-DDX10 oncogene on primary human CD34+ cells: role of a conserved helicase motif. Leukemia. 2010;24(5):1001-11.
22. Krivtsov AV, Armstrong SA. MLL translocations, histone modifications and leukaemia stem-cell development. Nat Rev Cancer. 2007;7(11):823-33.
23. Tosi S, Ballabio E, Teigler-Schlegel A, Boultwood J, Bruch J, Harbott J. Characterization of 6q abnormalities in childhood acute myeloid leukemia and identification of a novel t(6;11)(q24.1;p15.5) resulting in a NUP98-C6orf80 fusion in a case of acute megakaryoblastic leukemia. Genes Chromosomes Cancer. 2005;44(3): 225-32.
24. Su X, Drabkin H, Clappier E, Morgado E, Busson M, Romana S, et al. Transforming potential of the T-cell acute lymphoblastic leukemia-associated homeobox genes HOXA13, TLX1, and TLX3. Genes Chromosomes Cancer. 2006;45(9):846-55.
25. Valk PJ, Verhaak RG, Beijen MA, Erpelinck CA, Barjesteh van Waalwijk van Doorn Khosrovani S, Boer JM, et al. Prognostically useful gene-expression profiles in acute myeloid leukemia N Engl J Med. 2004; 350(16):1617-28.
26. Metzeler KH, Hummel M, Bloomfield CD, Spiekermann K, Braess J, Sauerland MC, et al. An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia. Blood. 2008; 112(10):4193-201.
27. Wouters BJ, Lowenberg B, Erpelinck-Verschueren CA, van Putten WL, Valk PJ, Delwel R. Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome. Blood. 2009;113(13):3088-91.
28. Pan Q, Zhu YJ, Gu BW, Cai X, Bai XT, Yun HY, et al. A new fusion gene NUP98-IQCG identified in an acute T-lymphoid/myeloid leukemia with a t(3;11)(q29q13;p15) del(3)(q29) translocation. Oncogene. 2008; 27(24):3414-23.
29. Badano JL, Leitch CC, Ansley SJ, May-Simera H, Lawson S, Lewis RA, et al. Dissection of epistasis in oligogenic Bardet-Biedl syndrome. Nature. 2006;439(7074): 326-30.
30. Ross ME, Mahfouz R, Onciu M, Liu HC, Zhou X, Song G, et al. Gene expression profiling of pediatric acute myelogenous leukemia. Blood. 2004;104(12):3679-87.
31. Kogan SC, Ward JM, Anver MR, Berman JJ, Brayton C, Cardiff RD, et al. Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice. Blood. 2002;100(1):238-45.
32. Akashi K, Traver D, Miyamoto T, Weissman IL. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature. 2000;404(6774): 193-7.
33. Cozzio A, Passegue E, Ayton PM, Karsunky H, Cleary ML, Weissman IL. Similar MLLassociated leukemias arising from selfrenewing stem cells and short-lived myeloid progenitors. Genes Dev. 2003;17 (24):3029-35.
34. Malinge S, Ragu C, Della-Valle V, Pisani D, Constantinescu SN, Perez C, et al. Activating mutations in human acute megakaryoblastic leukemia. Blood. 2008; 112(10):4220-6.
35. Takeda A, Sarma NJ, Abdul-Nabi AM, Yaseen NR. Inhibition of CRM1-mediated nuclear export of transcription factors by leukemogenic NUP98 fusion proteins. J Biol Chem. 2010;285(21):16248-57.